Physician profile
Allan Ruby
NPI 1285691709
$55,058.63
in general payments reported to CMS, 2019-2025
46 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $3,121 · 2021: $14K · 2022: $29K · 2023: $6,068 · 2024: $1,699 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,250 · Food and Beverage: $3,394 · Travel and Lodging: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,250.00 |
| Food and Beverage | $3,393.95 |
| Travel and Lodging | $263.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $49,211.71 | 2020-2024 | Acessa Provu System |
| Abbvie INC. | $717.41 | 2019-2025 | Orilissa, Lo Loestrin Fe, Qulipta |
| Hologic Sales and Service, LLC | $653.08 | 2022-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Coolseal Generator |
| Intuitive Surgical, INC. | $604.22 | 2021-2025 | Da Vinci Surgical System |
| Sumitomo Pharma America, INC. | $461.39 | 2023-2025 | Myfembree |
| Organon LLC | $265.15 | 2021-2025 | Nexplanon |
| Pfizer INC. | $259.87 | 2021-2024 | |
| Agile Therapeutics, INC. | $235.71 | 2021-2024 | Twirla |
| Gynesonics, INC. | $215.40 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $201.50 | 2023-2025 | Veozah |
| Millicent US INC | $200.61 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Exeltis, USA INC. | $191.59 | 2022-2025 | Slynd |
| Biohaven Pharmaceutical Holding Company Ltd. | $170.68 | 2022 | |
| Aspira Women'S Health INC | $164.14 | 2021-2022 | |
| Novo Nordisk INC | $151.09 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $148.92 | 2019-2025 | Paragard T 380a |
| Myovant Sciences INC. | $125.33 | 2022 | |
| Mayne Pharma Commercial LLC | $105.11 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.45 | 2023-2025 | Jardiance |
| Shield Therapeutics INC | $88.36 | 2023-2024 | Accrufer |
| Hologic INC | $72.68 | 2021 | |
| Dexcom, INC. | $54.18 | 2024-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $50.51 | 2022 | |
| Amgen INC. | $45.48 | 2022-2025 | Evenity, Prolia |
| Baxter Healthcare | $44.38 | 2024 | Tisseel |
| Biogen, INC. | $40.98 | 2025 | Zurzuvae |
| Kerecis Limited | $39.78 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Exact Sciences Corporation | $38.60 | 2023-2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.08 | 2020-2025 | Xifaxan |
| Conmed Corporation | $35.71 | 2022 | |
| Olympus America INC. | $28.78 | 2023 | |
| Lilly USA, LLC | $28.72 | 2024 | Zepbound, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $28.18 | 2023 | Vpriv |
| Idorsia Pharmaceuticals US INC | $27.39 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $27.06 | 2021-2025 | Bridion |
| Sobi, INC | $24.20 | 2022 | |
| Glaxosmithkline, LLC. | $22.21 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.90 | 2024 | Exparel |
| Janssen Pharmaceuticals, INC | $20.31 | 2023 | Xarelto |
| Convatec INC. | $18.78 | 2023 | |
| Heron Therapeutics, INC. | $17.73 | 2025 | Zynrelef |
| Davol INC. | $17.48 | 2023 | Arista Ah Flexitip |
| Amarin Pharma, INC. | $14.62 | 2022 | |
| Scynexis, INC. | $14.18 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.92 | 2019 | |
| Lupin INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Ruby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.